Literature DB >> 2388206

Analysis of a pediatric rheumatology clinic population.

A M Rosenberg1.   

Abstract

This analysis evaluates the role of a pediatric rheumatology clinic in assessing children with suspected rheumatic diseases and establishes relative disease frequencies in a clinic population. The study population comprised 875 children referred to a pediatric rheumatology clinic serving a population of 290,000 children. The mean annual referral rate was 113 patients. A diagnosis was established in 580 (66%) of whom 337 (58%) had a rheumatic disease. Of those with a rheumatic disease 156 (46%) had juvenile rheumatoid arthritis, 104 (31%) a spondyloarthropathy, 62 (18%) a connective tissue/collagen vascular disorder and 15 (5%) a variety of other conditions. Of the 243 diagnosed as having a nonrheumatic disease 79 (33%) had a mechanical or traumatic cause for musculoskeletal symptoms, 33 (14%) had an infection, 15 (6%) a neoplastic disorder and 71 (29%) a variety of other disorders. In addition, 45 children (19%) were evaluated because of family histories of rheumatic diseases or questionably abnormal symptoms or signs; after evaluation all these children were considered to be normal. The remaining group comprised 295 subjects (34%) for whom a definite diagnosis has not been made. In addition to diagnosing and caring for children with rheumatic disorders a pediatric rheumatology clinic serves to identify nonrheumatic conditions and provides information concerning relative frequencies and epidemiologic characteristics of childhood rheumatic diseases.

Entities:  

Mesh:

Year:  1990        PMID: 2388206

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

Review 1.  Non-inflammatory musculoskeletal disorders in childhood.

Authors:  J A Sills
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

2.  Profile of new referrals to a single pediatric rheumatology center in Turkey.

Authors:  Şerife Gül Karadağ; Hafize Emine Sönmez; Ayşe Tanatar; Figen Çakmak; Mustafa Çakan; Nuray Aktay Ayaz
Journal:  Rheumatol Int       Date:  2019-08-22       Impact factor: 2.631

3.  Teenager with an irritable hip, anaemia and malaise.

Authors:  R Hertzberger-ten Cate; B A Dijkmans; F C Breedveld
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

4.  Viewpoint: time for change in pediatric rheumatology.

Authors:  H I Huppertz
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

Review 5.  Juvenile onset spondyloarthropathies: therapeutic aspects.

Authors:  R Burgos-Vargas
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

6.  Recurrent limb pain in schoolchildren.

Authors:  I Abu-Arafeh; G Russell
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

Review 7.  Juvenile primary fibromyalgia syndrome.

Authors:  K K Anthony; L E Schanberg
Journal:  Curr Rheumatol Rep       Date:  2001-04       Impact factor: 4.592

8.  The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial.

Authors:  Sudha Visvanathan; Carrie Wagner; Joseph C Marini; Daniel J Lovell; Alberto Martini; Ross Petty; Ruben Cuttica; Patricia Woo; Graciela Espada; Marco Gattorno; Maria T Apaz; Eileen Baildam; Anders Fasth; Valeria Gerloni; Pekka Lahdenne; Pierre Quartier; Rotraud Saurenmann; Suzanne Travers; Alan Mendelsohn; Stephen Xu; Edward H Giannini; Nicolino Ruperto
Journal:  Pediatr Rheumatol Online J       Date:  2010-09-07       Impact factor: 3.054

9.  [Juvenile fibromyalgia syndrome].

Authors:  H Michels; K Gerhold; R Häfner; W Häuser; A Illhardt; K Mönkemöller; M Richter; L Schuchmann
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

10.  Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis.

Authors:  J Sieper; J Braun; E Döring; P Wu; J Heesemann; J Treharne; G Kingsley
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.